Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).

Journal for ImmunoTherapy of Cancer(2023)

引用 28|浏览7
暂无评分
摘要
NCT03117309.
更多
查看译文
关键词
clinical trials, phase II as topic,immunotherapy,kidney neoplasms
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要